DE602005025940D1 - Verfahren zum testen endokriner substanz in proben - Google Patents

Verfahren zum testen endokriner substanz in proben

Info

Publication number
DE602005025940D1
DE602005025940D1 DE602005025940T DE602005025940T DE602005025940D1 DE 602005025940 D1 DE602005025940 D1 DE 602005025940D1 DE 602005025940 T DE602005025940 T DE 602005025940T DE 602005025940 T DE602005025940 T DE 602005025940T DE 602005025940 D1 DE602005025940 D1 DE 602005025940D1
Authority
DE
Germany
Prior art keywords
analyte
endocrine substance
present
endocrine
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005025940T
Other languages
German (de)
English (en)
Inventor
Masaaki Kojima
Tatsuyuki Hachisu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shibayagi Co Ltd
Original Assignee
Shibayagi Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shibayagi Co Ltd filed Critical Shibayagi Co Ltd
Publication of DE602005025940D1 publication Critical patent/DE602005025940D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005025940T 2005-06-29 2005-11-22 Verfahren zum testen endokriner substanz in proben Expired - Lifetime DE602005025940D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005190003A JP4197180B2 (ja) 2005-06-29 2005-06-29 検体中の内分泌物質測定方法
PCT/JP2005/021443 WO2007000832A1 (ja) 2005-06-29 2005-11-22 検体中の内分泌物質測定方法。

Publications (1)

Publication Number Publication Date
DE602005025940D1 true DE602005025940D1 (de) 2011-02-24

Family

ID=37595091

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025940T Expired - Lifetime DE602005025940D1 (de) 2005-06-29 2005-11-22 Verfahren zum testen endokriner substanz in proben

Country Status (6)

Country Link
US (1) US8058011B2 (enExample)
EP (1) EP1898215B1 (enExample)
JP (1) JP4197180B2 (enExample)
AT (1) ATE495441T1 (enExample)
DE (1) DE602005025940D1 (enExample)
WO (1) WO2007000832A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5413766B2 (ja) * 2008-03-10 2014-02-12 株式会社シバヤギ レプチン測定方法
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
JP5504945B2 (ja) * 2010-02-12 2014-05-28 日東紡績株式会社 Ｆｔｃｄとその自己抗体との複合体の免疫測定方法、それに用いるキット及びそれを用いた癌判定方法
WO2017064678A1 (en) * 2015-10-15 2017-04-20 Biocon Limited Method for detecting neutralizing antibodies against recombinant human insulin in human serum
CN117054645A (zh) * 2016-09-06 2023-11-14 富士瑞必欧株式会社 甲状腺球蛋白的测定方法及测定试剂
EP3514539B1 (en) * 2016-09-13 2024-11-20 Fujirebio Inc. Cardiac troponin assay method and assay reagent
JP7138627B2 (ja) * 2017-05-17 2022-09-16 富士レビオ株式会社 インスリンの測定方法及び測定試薬
US12297227B2 (en) 2017-06-02 2025-05-13 Mediford Corporation Method for extracting target protein from biological sample and method for analyzing target protein
US20220196637A1 (en) * 2019-05-24 2022-06-23 Fujirebio Inc. Method and reagent for measuring thyroglobulin
CN111077323A (zh) * 2020-01-12 2020-04-28 天津市宝坻区人民医院 消除胰岛素自身抗体干扰的胰岛素测定试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855242A (en) * 1986-04-14 1989-08-08 Joslin Diabetes Center, Inc. Method of detecting antibodies
JPH0291572A (ja) * 1988-09-08 1990-03-30 Nippon Dpc Corp ウァルスｄｎａを用いた生物学的液体中の抗ｄｎａ抗体価の測定法および測定用キット
JPH03134567A (ja) * 1989-10-19 1991-06-07 Yamasa Shoyu Co Ltd 抗リン脂質抗体結合用担体、それを使用する免疫学的測定法およびキット
JP2789306B2 (ja) * 1994-11-15 1998-08-20 株式会社第一ラジオアイソトープ研究所 インスリン様成長因子の免疫学的測定方法ならびにインスリン様成長因子測定用キット
JPH11326322A (ja) 1998-05-06 1999-11-26 Shibayagi:Kk イヌインスリン測定用キットおよびそれを用いたイヌインスリン測定方法
JP3740898B2 (ja) * 1998-07-31 2006-02-01 三菱化学株式会社 生理活性成分の測定法
WO2000007021A1 (en) 1998-07-31 2000-02-10 Mitsubishi Chemical Corporation Method for assaying physiologically active component
US7189516B2 (en) * 2001-08-17 2007-03-13 Luminex Corporation Method for characterizing autoimmune disorders
US20050026826A1 (en) * 2003-01-17 2005-02-03 Margarethe Hoenig Feline proinsulin, insulin and constituent peptides

Also Published As

Publication number Publication date
JP4197180B2 (ja) 2008-12-17
US8058011B2 (en) 2011-11-15
EP1898215A4 (en) 2008-11-05
WO2007000832A1 (ja) 2007-01-04
JP2007010418A (ja) 2007-01-18
EP1898215A1 (en) 2008-03-12
ATE495441T1 (de) 2011-01-15
EP1898215B1 (en) 2011-01-12
US20090176252A1 (en) 2009-07-09

Similar Documents

Publication Publication Date Title
AR054851A1 (es) Amperometria regulada
BRPI0814201A2 (pt) Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador
ATE414166T1 (de) Glukosebiosensor und verfahren
BR112014016158A2 (pt) medições exatas de analito para tira de teste eletroquímica com base na(s) característica(s) física(s) detectada(s) da amostra contendo o analito
ATE524742T1 (de) Sequenzielle analyse biologischer proben mit zwischenbleichung eines fluoreszenzdetektors
ATE520026T1 (de) Sequenzielle analyse biologischer proben
WO2006026020A3 (en) Oncofetal fibronectin as a marker for disease and other conditions and methods for detection of oncofetal fibronectin
WO2007140962A3 (en) Improved measurement of vitamin d
CL2011002228A1 (es) Aparato para el analisis integrado de acidos nucleicos en tiempo real, y metodo de detecicion de dichas moleculas.
ATE442081T1 (de) Beurteilungsverfahren zum verarbeiten eines glukosekonzentrationssignals
EP3575781A3 (en) Test strips and method for reading test strips
ATE479152T1 (de) Analytisches verfahren und instrument
EP2573192A4 (en) METHOD AND KIT FOR DIAGNOSING DISEASE ASSOCIATED WITH AIM
ATE541216T1 (de) Fluoreszenztestverfahren
BR0317394A (pt) Uso de nicotinamida n-metiltransferase como um marcador para câncer colorretal
DE602005025940D1 (de) Verfahren zum testen endokriner substanz in proben
WO2005124356A3 (en) Use of protein cbp2 as a marker for colorectal cancer
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
EP2012116A4 (en) INDIVIDUAL DISCRIMINATION METHOD AND APPARATUS
ATE511636T1 (de) Verfahren zum nachweis biologischer organismen mittels raman-streuung
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
WO2016100117A3 (en) Accurate assay measurement of hydrophobic haptenic analytes
ATE393393T1 (de) Verwendung des proteins spee als marker für brustkrebs